KAREEN MARASHI: Open Payments
NPI 1891374104 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 16 payments from 9 companies in 2025. Trend: 2023 $163 · 2024 $156 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $97 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| PFIZER INC. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| BioMarin Pharmaceutical Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
Products named: TZIELD, ROTATEQ, KOSELUGO, PREVNAR 20, DUPIXENT, BEXSERO, VOXZOGO 1.2mg, PENMENVY.
Industry payments across NV — which companies pay providers there.
